Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214510 · ClinicalTrials.gov registry record · Phase 3
Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery
A Phase 3 study of Liver and Intrahepatic Bile Duct Disorder, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 3
- Development phase
- 101
- Enrollment target
- 1
- Study location
NCT03214510: Active Phase 3 study of Liver and Intrahepatic Bile Duct Disorder, sponsored by M.D. Anderson Cancer Center.
NCT03214510 is a Phase 3 study of Liver and Intrahepatic Bile Duct Disorder that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 101 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03214510, a Phase 3 study of Liver and Intrahepatic Bile Duct Disorder, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 101 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase III trial studies how well thoracic epidural analgesia or four-quadrant transversus abdominus plane block works in reducing pain in patients undergoing liver surgery. It is not yet known whether thoracic epidural analgesia or four-quadrant transversus abdominus plane block may help people to recover more completely and more quickly after surgery.
Primary Outcome
Will be recorded and compared between groups. Will be summarized using descriptive statistics including mean, standard deviation, median and range. Will be compared with 2-sample t- tests, Mann Whitney U tests or Wilcoxon rank sum tests as indicated.
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Fentanyl
- DEVICE Implanted Medical Device
- DRUG Hydromorphone Hydrochloride
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2017-10-04 |
| Est. Completion | 2026-07-31 |
| Phase | Phase 3 |
What the registry record for NCT03214510 still lists
NCT03214510 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Liver and Intrahepatic Bile Duct Disorder appearing as the primary indexed condition, and to 4 interventions - of which Bupivacaine is the first listed.
NCT03214510 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03214510 about?
NCT03214510 is a clinical study titled "Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery". This phase III trial studies how well thoracic epidural analgesia or four-quadrant transversus abdominus plane block works in reducing pain in patients undergoing liver surgery. It is not yet known whether thoracic epidural analgesia or four-quadrant transversus abdominus plane block may help people...
What is the current status of trial NCT03214510?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2017-10-04. Estimated completion is 2026-07-31.
What conditions does trial NCT03214510 study?
This clinical trial studies the following conditions: Liver and Intrahepatic Bile Duct Disorder.
What interventions are being tested in trial NCT03214510?
The interventions under investigation include: Bupivacaine (DRUG), Fentanyl (DRUG), Implanted Medical Device (DEVICE), Hydromorphone Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03214510?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03214510 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver and Intrahepatic Bile Duct Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03214510's enrollment target sits among peer trials
101 1680th of 2000 higher than 320 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI